These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10088635)

  • 1. Thrombosis in heritable hemolytic disorders.
    Barker JE; Wandersee NJ
    Curr Opin Hematol; 1999 Mar; 6(2):71-5. PubMed ID: 10088635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of complement activation in thrombosis and hemolytic anemias.
    Chapin J; Terry HS; Kleinert D; Laurence J
    Transfus Apher Sci; 2016 Apr; 54(2):191-8. PubMed ID: 27156108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation in the pathophysiology of hemolytic anemias.
    Cappellini MD
    Hematology Am Soc Hematol Educ Program; 2007; ():74-8. PubMed ID: 18024612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic Complications in Patients with Immune-Mediated Hemolysis.
    Capecchi M; Ciavarella A; Artoni A; Abbattista M; Martinelli I
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.
    Gladwin MT; Kato GJ
    Hematology Am Soc Hematol Educ Program; 2005; ():51-7. PubMed ID: 16304359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients.
    Isma'eel H; Arnaout MS; Shamseddeen W; Mahfouz R; Zeineh N; Jradi O; Taher A
    J Thromb Thrombolysis; 2006 Oct; 22(2):121-3. PubMed ID: 17008978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGGLUTINABILITY OF RED CELLS BY ANTI-I IN PATIENTS WITH THALASSEMIA MAJOR AND OTHER HAEMATOLOGICAL DISORDERS.
    GIBLETT ER; CROOKSTON MC
    Nature; 1964 Mar; 201():1138-9. PubMed ID: 14152804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Paroxysmal nocturnal hemoglobinuria: An unknown cause of thrombosis?].
    Doutrelon C; Skopinski S; Boulon C; Constans J; Viallard JF; Peffault de Latour R
    J Mal Vasc; 2015 Dec; 40(6):384-90. PubMed ID: 26205796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A closer look at paroxysmal nocturnal hemoglobinuria.
    Rachidi S; Musallam KM; Taher AT
    Eur J Intern Med; 2010 Aug; 21(4):260-7. PubMed ID: 20603032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential diagnosis of hemolytic anemias.
    Costea N
    Med Clin North Am; 1973 Mar; 57(2):289-302. PubMed ID: 4570931
    [No Abstract]   [Full Text] [Related]  

  • 11. A chemically induced rat model of hemolysis with disseminated thrombosis.
    Ezov N; Levin-Harrus T; Mittelman M; Redlich M; Shabat S; Ward SM; Peddada S; Nyska M; Yedgar S; Nyska A
    Cardiovasc Toxicol; 2002; 2(3):181-94. PubMed ID: 12665664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paroxysmal nocturnal hemoglobinuria].
    Wada H; Kanamaru A
    Nihon Rinsho; 1996 Sep; 54(9):2507-12. PubMed ID: 8890586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic anemia, iron deficiency and personal history of deep vein thrombosis: consider paroxysmal nocturnal hemoglobinuria.
    Gendron N; Arlet JB; Gaussem P; Radford-Weiss I; Dupeux S; Rosain J; La Tour RP; Darnige L
    Ann Biol Clin (Paris); 2017 Oct; 75(5):580-588. PubMed ID: 28958970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [STUDY OF THE SURVIVAL OF ERYTHROCYTES WITH THE CR-51 METHOD].
    GIUSTINA G; FERRARIO G
    Rass Clin Sci; 1963 Jun; 39():172-84. PubMed ID: 14044522
    [No Abstract]   [Full Text] [Related]  

  • 15. Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population - results from FLAER-based flowcytometry screening.
    Ahluwalia J; Naseem S; Sachdeva MU; Bose P; Bose SK; Kumar N; Thapa BR; Varma N; Chawla YK
    Eur J Haematol; 2014; 92(5):435-43. PubMed ID: 24400962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic anemias due to hemoglobinopathies.
    Poyart C; Wajcman H
    Mol Aspects Med; 1996 Apr; 17(2):129-42. PubMed ID: 8813715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic cells from -spectrin-deficient mice are sufficient to induce thrombotic events in hematopoietically ablated recipients.
    Wandersee NJ; Lee JC; Kaysser TM; Bronson RT; Barker JE
    Blood; 1998 Dec; 92(12):4856-63. PubMed ID: 9845553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient.
    Ray JG; Burows RF; Ginsberg JS; Burrows EA
    Haemostasis; 2000; 30(3):103-17. PubMed ID: 11014960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
    Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course and disease burden in patients with paroxysmal nocturnal hemoglobinuria by hemolytic status.
    Yenerel MN; Muus P; Wilson A; Szer J
    Blood Cells Mol Dis; 2017 Jun; 65():29-34. PubMed ID: 28437723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.